United Therapeutics CEO Chair Martine Rothblatt disposes of 9,500 shares for $4.81 million - UTHR News | RalliesUnited Therapeutics CEO Chair Martine Rothblatt disposes of 9,500 shares for $4.81 million
U
UTHR• Insider transaction details
- United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares on Aug. 13, 2026.
- A family trust sold 9,500 shares the same day at about $500.58 per share, in multiple trades.
- The trust’s beneficial ownership in common stock ended the day at 324,443 shares.
- The trust reported 141,910 stock options remaining.
•
